| 4:00–8:00 PM | Registration |
| 6:00–8:00 PM | Welcome Mixer |
| 7:00–8:00 AM | Breakfast |
| 8:00–8:10 AM | Welcome Remarks (Joint) |
| 8:10–9:00 AM | Keynote Address (Joint) |
| Michel C. Nussenzweig, HHMI/Rockefeller University Immune Strategies to Combat Infectious Diseases: What Works and What Doesn't |
| 9:00–11:15 AM | Transformative Technologies for Infectious Disease Therapeutics and Vaccines (Joint) |
| Debora Marks, Harvard Medical School Beating Viruses at their Own Game |
| Kevin Wiehe, Duke University Mutation Guided Immunogen Design |
| Pamela J Bjorkman, California Institute of Technology Structure based Vaccine Design |
| Darrell J. Irvine, Scripps Research Institute Harnessing Novel Vaccine Dosing and Adjuvant Strategies |
| Short Talk(s) Chosen from Abstracts |
| 9:30–9:50 AM | Coffee Break |
| 11:15–12:15 PM | Panel Discussion: Vaccine Hesitancy and Distrust (Joint) |
| 11:15–1:00 PM | Poster Setup |
| 11:15–5:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing |
| 2:30–4:30 PM | Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Designing Precision Vaccines |
| Bali Pulendran, Stanford University School of Medicine Next Generation Immunology to Design Precision Vaccines |
| Galit Alter, AstraZeneca Systems Immunology for Precision Vaccinology |
| Speaker to be Announced |
| Katherine Kedzierska, University of Melbourne Immune System Evolution through the Lifespan: Designing Precision Vaccines |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | Social Hour with Dinner |
| 7:30–10:00 PM | Posters |
| 7:00–8:00 AM | Breakfast |
| 8:00–11:00 AM | Tissue Targeting Vaccines |
| Laura K. Mackay, University of Melbourne Protection against Respiratory Pathogens: Role of Tissue-Resident Immunity |
| Mala K. Maini, University College London Protection against Hepatitis B: Compartmentalized Tissue-Specific Immunity |
| Ali H Ellebedy, Washington University School of Medicine Big and Juicy Lymph Nodes: Germinal Centers for Vaccine-Induced Immunity |
| Barbara L. Shacklett, University of California, Davis Genital Mucosal Immunity: T-cell immunity to HIV |
| Short Talk(s) Chosen from Abstracts |
| 9:00–9:20 AM | Coffee Break |
| 11:00–12:00 PM | Panel Discussion 2: Advances in Regulatory Framework for Combination Vaccines |
| 11:00–1:00 PM | Poster Setup |
| 11:00–5:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing |
| 3:00–4:30 PM | Career Roundtable |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Vaccines for Global Health |
| Simon J. Draper, University of Oxford New Malaria Vaccines: A Changing World |
| Thomas J Scriba, University of Cape Town A New TB Vaccine: Results of the M72/AS01B Phase 3 Trial |
| Teresa Lambe, University of Oxford Vaccines for Global Health |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | Social Hour with Dinner |
| 7:30–10:00 PM | Posters |
| 7:00–8:00 AM | Breakfast |
| 8:00–11:00 AM | New Frontiers of Vaccines: Cancer, Allergy and Beyond |
| Ugur Sahin †, BioNTech Therapeutic Cancer Vaccines |
| Jeffrey A Hubbell, New York University Synthetic Antigen Design for Targeting: From Cancer to Tolerogenic Vaccines |
| Saranya Sridhar, Sanofi Therapeutic Vaccines against Inflammatory Diseases |
| Short Talk(s) Chosen from Abstracts |
| 9:00–9:20 AM | Coffee Break |
| 11:00–12:00 PM | Panel Discussion 3: Academic-Industry Collaborations: Ways to Make it Work |
| 11:00–5:00 PM | On Own for Lunch |
| 2:30–4:30 PM | Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available |
| 5:00–6:45 PM | What are the Next Generation Methodologies to Revolutionize Vaccine Development? |
| Tor Biering-Sørensen, University of Copenhagen Real-World Individual Randomized Clinical Trials: FLUNITY |
| Corrina Pavetto †, Cidara Therapeutics, Inc. Antibody Drug Conjugates: A New Technology for Infectious Disease Prophylaxis |
| Kawsar R. Talaat, Johns Hopkins Bloomberg School of Public Health CHIM Studies: A New Pathway to License Vaccines |
| Short Talk(s) Chosen from Abstracts |
| 6:45–7:00 PM | Meeting Wrap-Up: Outcomes and Future Directions |
| 7:00–8:00 PM | Social Hour with Dinner |
| 7:30–10:00 PM | Posters |
| 12:00–11:59 PM | Departure |